Mintz advised SightLine Applications, a leading developer of sensor processing software for autonomous and uncrewed systems, backed by Artemis, on its acquisition of Athena AI, an Australia-based specialist in AI-enabled computer vision and decision support for defense applications. 

Mintz advised Searchlight Cyber, a portfolio company of Charlesbank Capital Partners, on the acquisition of Assetnote, an Australian-based Attack Surface Management (ASM) platform provider. 

Mintz represented Quorum Cyber Security, a platform company of Charlesbank Capital Partners, in its acquisition of Kivu Consulting, Inc., a global cybersecurity firm specializing in Incident Response.

Mintz advised Artemis, a Boston-based private equity firm focused on partnering with differentiated industrial tech companies, on the acquisition of Richland Glass Company, LLC, an Advanced Materials manufacturer of specialty glass containment products and solutions. 

Mintz advised Foster Corporation, a differentiated compounder of biomedical polymers used in the high-growth healthcare and medical device industry, on an acquisition by GEON® Performance Solutions, a global leader in the formulation, development, and manufacture of performance polymer solutions.

Mintz advised DW Healthcare Partners (DW) on the organization of a continuation vehicle to extend DW’s investment in its portfolio company, Med Learning Group, a continuing medical education company, and to provide additional capital to support the company’s further development and growth. 

Mintz advised Artemis Capital Partners, a Boston-based private equity firm focused on partnering with differentiated industrial tech companies, on its acquisition of Diamond Antenna and Microwave Corporation, a developer of advanced radio frequency rotary joints and rotating subsystems serving mission critical ground, shipboard, submarine, aircraft, commercial, and space applications.

Mintz advised Charlesbank Capital Partners (“Charlesbank”), a middle-market private equity firm with more than $22 billion in total assets, on a strategic investment with IMPLAN Group LLC (“IMPLAN”), a leading provider of economic impact data and analytical software. 

Private Equity Co-chair Gregory Fine spoke to S&P Global about the increased number of earnout provisions in M&A when the seller is a private equity firm.

Mintz has appointed Members Gregory Fine and Matthew T. Simpson to co-lead the Private Equity practice alongside current chair, Kurt Steinkrauss. The change is effective immediately.

Members Gregory Fine, Matthew T. Simpson and Kurt Steinkrauss were featured in an article published by The Deal highlighting their appointment to co-lead the Firm's Private Equity practice.

Mintz attorneys in Boston, New York, and Washington, DC, closed four Private Equity transactions in the past month. Along with acquisitions for Charlesbank Capital Partners, DIF Capital Partners portfolio company Joink LLC, and Artemis Capital Partners, the firm represented the CEO and some managers of Salary.com in the sale of most of the company’s equity interests to Accel-KKR.

Mintz completed a deal as counsel to Med-Pharmex in its sale to British-owned veterinary products developer and manufacturer Dechra Pharmaceuticals. Through the sale, Dechra will gain further access and nearly 40 years of experience in the U.S. veterinary health market.